|
News : access to newsroom
|
|
|
Medincell and Sogeval under partnership
April 16, 2008
Montpellier, France. An agreement between Medincell S.A. and Sogeval S.A. has been signed to partner on an exclusive program using MedinGel™ technologies for undisclosed companion animal applications. Sogeval is a French veterinary drug company located in Laval, producing and marketing drugs and veterinary specialities under its own brand and for third party companies. Located in the heart of Europe's largest agri-food region, Sogeval has enjoyed continuous ... Continued here
|
|
|
Careers :
|
|
|
MedinCell is a young, innovative and dynamic biotech company. We are interested in people working in the field of delivery systems, artificial polymers, and more generally chemistry, biochemistry, pharmacology, toxicology and regulatory affairs. For careers opportunities, feel free to explore our job career menu.
|
|
|
|
|
Medincell is a leading biopharmaceutical company that offers innovative technologies in Drug Delivery. The corporation, founded in 2002, assists Human and Animal Health companies with MedinGel™, MedinCare™ and MedinHub™, its advanced polymeric drug delivery systems.
Our technologies have the potential to successfully deliver a broad range of compounds (such as small, sensitive, peptides, proteins, or other difficult-to-deliver molecules) thanks to their Slow Release Formulations. These technologies also allow regulatory advantages and provide a strong international protection.
Our scientific team is internationally renowned : our patented technologies have been proven to enhance the delivery of active agents, improving patient compliance and convenience thanks to advantageous pharmacokinetic profiles.
Since 2006, MedinCell works with partners convinced that innovation is the key to health improvement.
Welcome to MedinCell !
|
|
|
Our Technologies
MedinGel™, MedinCare™ and MedinHub™ are innovative polymer-based drug delivery systems which provide a powerful tool for human and animal health…… Learn more >
Partnerships
MedinCell is enthusiastically seeking to establish new collaborations and develop innovative solutions… Learn more >
Feasibility studies
Our company has designed an efficient, easy to handle, collaborative procedure, that comprises three technological levels of exploration… Learn more >
Investor Relations
MedinCell is 100% privately owned and has been developed to ensure IPO in 2010. Private or public investors are welcome to join the company’s capital….. Learn more >
|
|
|
